Overview

Acamprosate in the Treatment of Binge-Eating Disorder

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to determine the efficacy (how well it works), tolerability and safety of acomprosate compared with placebo in patients with binge eating disorder.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Lindner Center of HOPE
Collaborators:
Forest Laboratories
University of Cincinnati
Treatments:
Acamprosate